Latest News

Intranasal ketamine confers rapid antidepressant effect in depression

The first controlled evidence has been released showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect ?- within 24 hours ?- and was well tolerated in patients with treatment-resistant major depressive disorder. One of the most common NMDA receptor antagonists, ketamine is an FDA-approved anesthetic. It has been used in animals and humans for years. Ketamine has also been a drug of abuse and can lead to untoward psychiatric or cognitive problems when misused. In low doses, ketamine shows promise in providing rapid relief of depression, with tolerable side effects.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Brain networks 'hyper-connected' in young adults who had depression

  • New treatment for Multiple Sclerosis being investigated

  • Intervention needed for survivors of childhood burns

  • How studying damage to prefrontal lobe has helped unlock the brain's mysteries

  • Protein glue shows potential for use with biomaterials

  • Electric current to brain boosts memory: May help treat memory disorders from stroke, Alzheimer's, brain injury

  • Serotonin deficiency? Study throws into question long-held belief about depression

  • Xenon exposure shown to erase traumatic memories

  • Inside the teenage brain: New studies explain risky behavior

  • Readers with dyslexia have disrupted network connections in the brain, map the circuitry of dyslexia shows

  •